Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
News
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or…
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein…
Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
OV101 program in Angelman syndrome to pause pending full analysis of NEPTUNE trial and discussions…
Allena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Leading Independent Proxy Firms ISS and Glass Lewis Recommend Ocugen Stockholders Vote “FOR” Reverse Stock Split and Authorized Shares Amendment Proposals
MALVERN, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
Cambium Networks Corporation Announces Launch of Secondary Offering
ROLLING MEADOWS, Ill., Dec. 01, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”),…
Optinose Announces Changes to Board of Directors
YARDLEY, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020
SAN DIEGO, Dec. 01, 2020 (GLOBE NEWSWIRE) — Travere Therapeutics (NASDAQ: TVTX) today announced that…